These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9706604)

  • 1. [The usefulness of the desensitization to rifampin in the treatment of mycobacterial disease in patients with AIDS].
    Arrizabalaga J; Casas A; Camino X; Iribarren JA; Rodríguez Arrondo F; Von Wichmann MA
    Med Clin (Barc); 1998 Jun; 111(3):103-4. PubMed ID: 9706604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Desensitization to rifampicin. Apropos of a case].
    Alonso MD; de la Hoz B; Cuevas M; Beick A
    Med Clin (Barc); 1996 Mar; 106(8):319. PubMed ID: 8667695
    [No Abstract]   [Full Text] [Related]  

  • 3. [Desensitization to rifampicin].
    Portu Zapirain J; Aldamiz-Etxebarria San Sebastián M; Fernández Zubiaga M; Jiménez Caudevilla C
    Med Clin (Barc); 1997 Jan; 108(1):35. PubMed ID: 9053576
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral desensitization to rifampin and ethambutol in mycobacterial disease.
    Matz J; Borish LC; Routes JM; Rosenwasser LJ
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):815-7. PubMed ID: 8118654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate hypersensitivity to rifampicin in 3 patients: diagnostic procedures and induction of clinical tolerance.
    Buergin S; Scherer K; Häusermann P; Bircher AJ
    Int Arch Allergy Immunol; 2006; 140(1):20-6. PubMed ID: 16514245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
    Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
    Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid oral desensitization to isoniazid, rifampin, and ethambutol.
    Kim JH; Kim HB; Kim BS; Hong SJ
    Allergy; 2003 Jun; 58(6):540-1. PubMed ID: 12757467
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case report on desensitization therapy of hypersensitivity to enviomycin (EVM) (author's transl)].
    Yoshimoto K; Misaki K; Tsuneishi K; Kim S
    Kekkaku; 1977 Nov; 52(11):587-9. PubMed ID: 599779
    [No Abstract]   [Full Text] [Related]  

  • 9. A regimen containing rifabutin for the treatment of tuberculosis in patients intolerant to rifampin.
    Tattevin P; Revest M; Dupont M; Arvieux C; Michelet C
    Clin Infect Dis; 2003 Jan; 36(1):127-8. PubMed ID: 12491218
    [No Abstract]   [Full Text] [Related]  

  • 10. [Allergies--specific immunotherapy for rifampicin allergy].
    Pneumologie; 2007 Oct; 61(10):624. PubMed ID: 17922380
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rifampicin toxicity in HIV-infected patients: A study of its incidence and the risk factors].
    Gort A; Falguera M; Schoenenberger JA
    An Med Interna; 1997 Nov; 14(11):559-64. PubMed ID: 9445581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe immunoallergic reaction in a patient treated for two months continuously with rifampicin].
    Fardet L; Lalande V; Meyohas MC; Frottier J; Meynard JL
    Presse Med; 1999 Nov; 28(37):2037-8. PubMed ID: 10605471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsuccessful rapid intravenous desensitization to rifampicin.
    Dutau H; Saadjian M; Bonneau V; Charpin D
    Allergy; 2000 Aug; 55(8):778-9. PubMed ID: 10955706
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaphylaxis during rapid oral desensitization to rifampicin.
    Syrigou E; Grapsa D; Nanou E; Zande M; Vassias A; Gkiozos I; Syrigos K
    J Allergy Clin Immunol Pract; 2016; 4(1):173-4. PubMed ID: 26603634
    [No Abstract]   [Full Text] [Related]  

  • 16. Shock and cerebral infarct after rifampin re-exposure in a patient infected with human immunodeficiency virus.
    Martínez E; Collazos J; Mayo J
    Clin Infect Dis; 1998 Nov; 27(5):1329-30. PubMed ID: 9827298
    [No Abstract]   [Full Text] [Related]  

  • 17. Saquinavir and rifampicin for tuberculosis and AIDS: new considerations.
    Torres TS; Rolla VC
    Int J Tuberc Lung Dis; 2006 Nov; 10(11):1302; author reply 1302-3. PubMed ID: 17131794
    [No Abstract]   [Full Text] [Related]  

  • 18. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential rapid oral desensitization to rifampin and moxifloxacin for the treatment of active mycobacterium tuberculosis.
    Benken ST; Nyenhuis SM; Dunne S
    J Allergy Clin Immunol Pract; 2017; 5(1):195-197. PubMed ID: 27838324
    [No Abstract]   [Full Text] [Related]  

  • 20. Life-threatening, multiple hypersensitivity reactions induced by rifampicin in one patient with pulmonary tuberculosis.
    Luzzati R; Giacomazzi D; Franchi F; Barcobello M; Vento S
    South Med J; 2007 Aug; 100(8):854-6. PubMed ID: 17715477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.